Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The study is to compare the rate and extent of absorption of a generic formulation with that of a reference for mulation when given as equal labeled dose. The study will be randomized, open-label, single dose, two way crossover design with two-period, two-treatment and two-sequence under fasting condition and at least 7 days washout period between the doses.
Epistemonikos ID: ecdab0d663e8f5ca1e120302497fdb24c3a1bd36
First added on: May 15, 2024